Citation Impact
Citing Papers
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Rodent-borne diseases and their risks for public health
2009 Standout
Attributing the Human Disease Burden of Foodborne Infections to Specific Sources
2009
Habitat Factors Associated with Bank Voles ( Clethrionomys glareolus ) and Concomitant Hantavirus in Northern Sweden
2005
In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics
2006
BIGSdb: Scalable analysis of bacterial genome variation at the population level
2010 Standout
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
2013
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Could oral fluid be used to evaluate anti-hepatitis A virus status in individuals living in difficult-to-access areas?
2012
Environmental and demographic risk factors for campylobacteriosis: do various geographical scales tell the same story?
2012
The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action
2016 StandoutNobel
Junín Virus Infection of Human Hematopoietic Progenitors Impairs In Vitro Proplatelet Formation and Platelet Release via a Bystander Effect Involving Type I IFN Signaling
2010
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
Mechanisms of Pathogenesis, Infective Dose and Virulence in Human Parasites
2012
Global epidemiology and genotype distribution of the hepatitis C virus infection
2014
Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH?
2005
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
2009
Evidence for Superantigen Involvement in Severe Group A Streptococcal Tissue Infections
2001
Burden of liver diseases in the world
2018 Standout
New opportunities for field research on the pathogenesis and treatment of Lassa fever
2007
A case–control study of risk factors for sporadic campylobacter infections in Denmark
2003
A Stochastic Assessment of the Public Health Risks of the Use of Macrolide Antibiotics in Food Animals
2008
Attribution of Foodborne Illnesses, Hospitalizations, and Deaths to Food Commodities by using Outbreak Data, United States, 1998–2008
2013 Standout
The Effectiveness of Mobile-Health Technology-Based Health Behaviour Change or Disease Management Interventions for Health Care Consumers: A Systematic Review
2013 Standout
The 1995 Kikwit Ebola outbreak: lessons hospitals and physicians can apply to future viral epidemics
2008
Melioidosis
2012 Standout
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
The Human/Animal Interface: Emergence and Resurgence of Zoonotic Infectious Diseases
2007
beta Blockade after myocardial infarction: systematic review and meta regression analysis
1999
Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections
2012
The changing epidemiology of hepatitis C virus infection in Europe
2007
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Drug Interactions with Bacillus anthracis Topoisomerase IV: Biochemical Basis for Quinolone Action and Resistance
2011
Lysogenic Transfer of Group AStreptococcusSuperantigen Gene among Streptococci
2008 StandoutNobel
Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis
2020 Standout
Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague
2010 StandoutNobel
Uncovering the mysteries of hantavirus infections
2013
Brucellosis: A re-emerging zoonosis
2009 Standout
Plague
2007
CampylobacterGenotyping to Determine the Source of Human Infection
2009
Biological weapons
2006
Foodborne Illness Acquired in the United States—Major Pathogens
2010 Standout
Epidemiology of Hepatitis C Virus (HCV) Infection
2006
Campylobacter genotypes from food animals, environmental sources and clinical disease in Scotland 2005/6
2009
Human brucellosis
2007 Standout
Global Burden of Human Brucellosis: A Systematic Review of Disease Frequency
2012 Standout
The bacterial gene lfpA influences the potent induction of calcitonin receptor and osteoclast-related genes in Burkholderia pseudomallei-induced TRAP-positive multinucleated giant cells
2006
How should meta‐regression analyses be undertaken and interpreted?
2002 Standout
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
NAFLD: A multisystem disease
2015 Standout
Preventing Campylobacter at the Source: Why Is It So Difficult?
2013
Mechanism of Quinolone Action and Resistance
2014 Standout
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
The burden of liver disease in Europe: A review of available epidemiological data
2013
Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: A review
2018 Standout
The immunopathogenesis of sepsis
2002 StandoutNature
Climate change and human health: present and future risks
2006 Standout
Toxin‐Gene Profile Heterogeneity among Endemic Invasive European Group A Streptococcal Isolates
2003 StandoutNobel
Host Association of Campylobacter Genotypes Transcends Geographic Variation
2010
RNase Y-mediated regulation of the streptococcal pyrogenic exotoxin B
2018 StandoutNobel
Clinical Escherichia coli Strains Carrying stx Genes: stx Variants and stx -Positive Virulence Profiles
2002
Fly Transmission ofCampylobacter
2005
Septicaemia in an Austrian neonatal intensive care unit: a 7‐year analysis
1998
In Vivo Protective Role of Human Group IIA Phospholipase A2 against Experimental Anthrax
2005
2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
2003 Standout
Pandemics, tourism and global change: a rapid assessment of COVID-19
2020 Standout
Global Epidemiology of Campylobacter Infection
2015 Standout
Late-Onset Sepsis in Very Low Birth Weight Neonates: The Experience of the NICHD Neonatal Research Network
2002 Standout
Psychosocial effects of an Ebola outbreak at individual, community and international levels
2016 Standout
Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China
2020 Standout
Food Animals and Antimicrobials: Impacts on Human Health
2011 Standout
Site-Specific Manifestations of Invasive Group A Streptococcal Disease: Type Distribution and Corresponding Patterns of Virulence Determinants
2003
Meat consumption, health, and the environment
2018 StandoutScience
Application of molecular epidemiology to understanding campylobacteriosis in the Canterbury region of New Zealand
2012
Relating increasing hantavirus incidences to the changing climate: the mast connection
2009
Impact of Heat Stress on Poultry Production
2013 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
Measuring accessibility: positive and normative implementations of various accessibility indicators
2012 Standout
Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis
2018 StandoutNobel
Underreporting of communicable diseases in the prefecture of Achaia, western Greece, 1999-2004 – missed opportunities for early intervention
2010
Disease Risks from Foods, England and Wales, 1996–2000
2005
Works of F van Loock being referenced
A Campylobacter Colifoodborne Outbreak in Belgium
2000
A case-control study of sporadic infection with O157 and non-O157 verocytotoxin-producing Escherichia coli
1999
Prevalence of hepatitis A, B and C in the Flemish population
1997
A population-based prevalence study of hepatitis A, B and C virus using oral fluid in Flanders, Belgium
2007
Etude Epidemiologique Sur Les Septicemies Et Meningites Neonatales En Belgique
1995
Risk factors for human hantavirus infection: Franco-Belgian collaborative case-control study during 1995-6 epidemic
1999
A Case‐Control Study after a Hantavirus Infection Outbreak in the South of Belgium: Who Is at Risk?
1999
Bichat guidelines for the clinical management of anthrax and bioterrorism-related anthrax
2004
The Dioxin Crisis as Experiment To Determine Poultry-Related Campylobacter Enteritis
2002
Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses
2004
Epidemiology of hepatitis C in Belgium: present and future.
2002
The Early Warning and Response System for communicable diseases in the EU: an overview from 1999 to 2005
2006
Bichat guidelines for the clinical management of glanders and melioidosis and bioterrorism-related glanders and melioidosis
2004
Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis
2004
Bichat guidelines for the clinical management of plague and bioterrorism-related plague
2004
Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993–1994
2000